Radyolojik İzole Sendrom

Okuda DT, Mowry EM, Beheshtian A, et al. Incidental MRI anomalies suggestive of multiple sclerosis: the radiologically isolated syndrome. Neurology. 2009;72(9):800-805.

Hosseiny M, Newsome SD, Yousem DM. Radiologically Isolated Syndrome: A Review for Neuroradiologists. AJNR Am J Neuroradiol. 2020;41(9):1542-1549.

Forslin Y, Granberg T, Jumah AA, et al. Incidence of Radiologically Isolated Syndrome: A Population-Based Study. AJNR Am J Neuroradiol. 2016;37(6):1017-1022.

Gabelic T, Ramasamy DP, Weinstock-Guttman B, et al. Prevalence of radiologically isolated syndrome and white matter signal abnormalities in healthy relatives of patients with multiple sclerosis. American Journal of Neuroradiology. 2014;35(1):106-112.

Barkhof F, Filippi M, Miller DH, et al. Comparison of MRI criteria at first presentation to predict conversion to clinically definite multiple sclerosis. Brain 1997; 120: 2059–2069.

Thompson AJ, Banwell BL, Barkhof F, et al. Diagnosis of multiple sclerosis: 2017 revisions of the McDonald criteria. 2018 ;17(2):162-173.

Lebrun-Frénay C, Okuda DT, Siva A, et al. The radiologically isolated syndrome: revised diagnostic criteria. Brain. 2023;146(8):3431-3443.

Okuda DT, Lebrun-Frénay C. Radiologically isolated syndrome in the spectrum of multiple sclerosis. Multiple Sclerosis Journal. 2024;30(6):630-636.

Okuda DT, Siva A, Kantarci O, et al. Radiologically isolated syndrome: 5-year risk for an initial clinical event. PLoS ONE 2014; 9(3): e90509.

Lebrun-Frenay C, Kantarci O, Siva A, et al. Radiologically isolated syndrome: 10-year risk estimate of a clinical event. Ann Neurol 2020; 88(2): 407–417.

Makhani N, Lebrun C, Siva A, et al. Oligoclonal bands increase the specificity of MRI criteria to predict multiple sclerosis in children with radiologically isolated syndrome. Mult Scler J Exp Transl Clin 2019; 5(1): 836664.

Okuda DT, Lebrun-Frénay C. Radiologically isolated syndrome in the spectrum of multiple sclerosis. Multiple Sclerosis Journal. 2024;30(6):630-636.

Smets I. Presymptomatic MS or radiologically isolated syndrome (RIS) should be actively monitored and treated – NO. Mult Scler. 2023;29(7):795.

Lebrun-Frénay C, Siva A, Sormani MP, et al. Teriflunomide and Time to Clinical Multiple Sclerosis in Patients With Radiologically Isolated Syndrome: The TERIS Randomized Clinical Trial. JAMA Neurol. 2023;80(10):1080-1088.

Okuda DT, Kantarci O, Lebrun-Frénay C, et al. Dimethyl Fumarate Delays Multiple Sclerosis in Radiologically Isolated Syndrome. Ann Neurol. 2023;93(3):604-614.